LABCORP HOLDINGS INC.

LHSEC EDGAR

Services-Medical LaboratoriesCIK: 920148

Concept	FY2025	FY2024	FY2023	FY2021	FY2020
Revenues	$12.2B	$11.9B	$13.1B	$14.0B	$11.3B
Cost of Goods and Services Sold	—	—	—	—	—
Gross Profit	$3.4B	$3.7B	$5.0B	$5.0B	$3.2B
Selling, General and Administrative Expense	$2.0B	$1.8B	$1.7B	$1.7B	$1.6B
Operating Income (Loss)	$725.6M	$1.4B	$3.0B	$2.4B	$1.3B
Interest Expense	$199.6M	$179.8M	$211.8M	$207.4M	$244.2M
Nonoperating Income (Expense)	—	—	—	—	-$57.4M

Concept	FY2025	FY2024	FY2023	FY2021	FY2020
Assets	$18.4B	$16.7B	$20.2B	$20.4B	$18.0B
Assets, Current	$4.8B	$3.8B	$4.6B	$5.3B	$3.0B
Cash and Cash Equivalents, at Carrying Value	$536.8M	$320.6M	$320.6M	$1.5B	$316.6M
Accounts Receivable, after Allowance for Credit Loss, Current	$1.9B	$1.9B	$1.8B	$2.3B	$1.5B
Inventory, Net	$493.2M	$474.6M	$470.6M	$401.4M	$244.7M
Liabilities	$10.3B	$8.8B	$10.0B	$10.1B	$10.5B
Liabilities, Current	$3.3B	$3.2B	$3.1B	$2.8B

Concept	FY2025	FY2024	FY2023	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	$1.3B	$2.0B	$3.1B	$2.1B	$1.3B
Net Cash Provided by (Used in) Investing Activities	-$1.2B	-$1.7B	-$884.6M	-$643.2M	$206.7M
Net Cash Provided by (Used in) Financing Activities	-$59.3M	-$1.3B	-$2.1B	-$517.4M	-$1.4B
Payments to Acquire Property, Plant, and Equipment	$453.6M	$429.3M	$421.5M	$381.7M	$379.8M
Payments of Dividends	$254.0M	$195.2M	—	—	—
Payments for Repurchase of Common Stock	$1.0B	$1.1B	$1.7B	$100.0M	$700.0M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)